Grail (GRAL) Other financing activities (2023 - 2025)

Grail's (GRAL) quarterly Other financing activities came in at $932.3 million in Q2 2024, up 198.81% on a QoQ basis from $312.0 million in Q1 2024.

Grail (GRAL) Other financing activities (2023 - 2025) Analysis & Trends

Grail (GRAL) has 2 years of Other financing activities data on file, last reported at $932.3 million in Q2 2024.

Quarterly Other financing activities changed N/A year-over-year to $932.3 million in Q2 2024, while the trailing twelve-month figure through Mar 2025 was $932.3 million (changed N/A YoY) and the FY2024 annual result came in at $1.2 billion, up 168.17% from the prior year.
Other financing activities improved to $932.3 million in Q2 2024, from $312.0 million in the prior quarter.
In the past five years, Other financing activities ranged from a high of $932.3 million in Q2 2024 to a low of $86.0 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	Grail	3.56 Bn	2.70 Bn	21.34 Mn

Download Data